Structure Therapeutics Inc. (GPCR) — 10-Q Filings
All 10-Q filings from Structure Therapeutics Inc.. Browse 5 Quarterly Report reports with AI-powered summaries and risk analysis.
10-Q Filings (5)
-
Structure Therapeutics Bolsters Capital, Faces Revenue Void
— Aug 6, 2025 Risk: high
Structure Therapeutics Inc. reported no revenue for the three and six months ended June 30, 2025, consistent with its clinical-stage status. The company's net l -
Structure Therapeutics Files Q1 2025 10-Q
— May 8, 2025 Risk: low
Structure Therapeutics Inc. filed its 10-Q for the period ending March 31, 2025. The company, formerly known as ShouTi Inc., is in the pharmaceutical preparatio -
Structure Therapeutics Q3 2024 Update: Cash Position and Name Change
— Nov 13, 2024 Risk: medium
Structure Therapeutics Inc. filed its 10-Q for the period ending September 30, 2024. The company reported cash and cash equivalents of $171.8 million as of Sept -
Structure Therapeutics Q2 2024: Strong Cash Position
— Aug 8, 2024 Risk: medium
Structure Therapeutics Inc. reported its financial results for the quarter ended June 30, 2024. The company's filing indicates a significant cash position, with -
Structure Therapeutics Inc. Files 10-Q for Q1 2024
— May 9, 2024 Risk: medium
Structure Therapeutics Inc. (GPCR) filed a Quarterly Report (10-Q) with the SEC on May 9, 2024. Structure Therapeutics Inc. filed its 10-Q report for the period
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX